Shire agrees terms of £46bn Takeda takeover offer | Business News | Sky News
It's Official! Takeda Pharma to Buy Shire for $62.2 Billion | BioSpace
Takeda Acquires Shire for $64 Billion
Takeda chief takes £46bn gamble on Shire takeover | Financial Times
Global Firms Play Big Role as Japan's Takeda Wins Battle for Shire in $62 Billion Deal
Takeda-Shire deal: the strategy behind Japan's largest foreign acquisition - Pharmaceutical Technology
Takeda seeks to divest $10bn of assets after £46bn Shire deal | Financial Times
Analysts Question Takeda-Shire Deal, Speculate on Bidding War | BioSpace
Takeda's record Shire deal could put it in global top 10 - Independent.ie
Takeda Pharmaceutical and Shire receive shareholders' approval for Takeda-Shire deal | AlphaStreet
Does Takeda Want In on Ophthalmology?
Shire in good shape on verge of Takeda sale
Takeda reaches $62B deal to buy Shire - Drug Delivery Business
THIS ANNOUNCEMENT IS AN ADVERTISEMENT AND NOT A PROSPECTUS OR PROSPECTUS EQUIVALENT DOCUMENT AND INVESTORS SHOULD NOT MAKE ANY I
Reviewing The Takeda-Shire Merger (NASDAQ:SHPG) | Seeking Alpha
News Release
Takeda to float 7.5bn euros in bonds to fund Shire purchase - Nikkei Asia
Japan's Takeda agrees $62 billion takeover of Shire
Shire and Takeda come to terms with a $64B deal, the biggest pharma M&A in years | Fierce Pharma
Takeda closes in on $62bn deal for Shire - Nikkei Asia
Takeda Pharmaceutical Agrees $62.4 Billion Takeover of Shire - TheStreet
Shire and Takeda Plan to Announce a Deal Wednesday: Sources
Takeda's $60bn offer for Shire rejected as too low - Nikkei Asia
Pharma giant Takeda enters into $7.5bn loan agreement to fund Shire takeover
Shire and Takeda to announce preliminary deal after breakthrough in merger talks: Reuters, citing sources
A combined Takeda Shire would be the ninth biggest pharma company in the world by sales - Verdict
